8,598 research outputs found
A drug education manual concerning illicit drugs and psychotropics - For teachers in secondary schools in the Member States of the European Community. Medicine. EUR 10594 EN
Tree Level Unitarity Bounds for the Minimal B-L Model
We have derived the unitarity bounds in the high energy limit for the minimal
B-L extension of the Standard Model by analysing the full class of Higgs and
would-be Goldstone boson two-to-two scatterings at tree level. Moreover, we
have investigated how these limits could vary at some lower critical value of
the energy.Comment: 20 pages, 4 figures, 2 tables; 1d figure modified, typos corrected,
bibliography augmented; published in PRD after minor adjustmen
The Z' boson of the minimal B-L model at future Linear Colliders in e+e- --> mu+mu-
We study the capabilities of future electron-positron Linear Colliders, with
centre-of-mass energy at the TeV scale, in accessing the parameter space of a
boson within the minimal model. We carry out a detailed comparison
between the discovery regions mapped over a two-dimensional configuration space
( mass and coupling) at the Large Hadron Collider and possible future
Linear Colliders for the case of di-muon production. As known in the literature
for other models, we confirm that leptonic machines, as compared to the
CERN hadronic accelerator, display an additional potential in discovering a
boson as well as in allowing one to study its properties at a level of
precision well beyond that of any of the existing colliders.Comment: 5 pages, proceeding of LC09 (Perugia), published by the Italian
Physical Society in the Nuovo Cimento C (Colloquia
A singlet-triplet extension for the Higgs search at LEP and LHC
We describe a simple extension of the standard model, containing a scalar
singlet and a triplet fermion. The model can explain the possible enhancement
in the decay at the LHC together with the excess
found in the Higgs boson search at LEP2. The structure of the model is
motivated by a recent argument, that was used to explain the number of fermion
generations. For the sake of completenes we also considered the contributions
from higher multiplets.Comment: 12 pages, 2 figure
An ounce of prevention is worth a pound of cure | The Smeltermen of Anaconda in War and Peace, 1942-1945
[2017 Honorable Mention] The American Dream (Some Restrictions May Apply): Racial Boundaries to Class Mobility in American Immigration Narratives
This paper analyzes three works of fiction to see the role that race plays in immigrants\u27 ability to achieve social mobility.https://digitalcommons.csumb.edu/esa_submissions/1021/thumbnail.jp
Experimental Chemotherapy Treatment for Advance Stage Breast Cancer: Judicial Interpretation of Insurance Policy Coverage
Scaling function in AdS/CFT from the O(6) sigma model
Asymptotic behavior of the anomalous dimensions of Wilson operators with high
spin and twist is governed in planar N=4 SYM theory by the scaling function
which coincides at strong coupling with the energy density of a two-dimensional
bosonic O(6) sigma model. We calculate this function by combining the two-loop
correction to the energy density for the O(n) model with two-loop correction to
the mass gap determined by the all-loop Bethe ansatz in N=4 SYM theory. The
result is in agreement with the prediction coming from the thermodynamical
limit of the quantum string Bethe ansatz equations, but disagrees with the
two-loop stringy corrections to the folded spinning string solution.Comment: 25 pages, 2 figure
Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: A single institutional experience.
The objectives of this study were to evaluate the effectiveness of nab-paclitaxel plus gemcitabine (NAB-P/GEM) regimen in an unselected population of patients with advanced inoperable or metastatic pancreatic cancer (PC), and to identify the prognostic factors influencing overall survival (OS). EXPERIMENTAL DESIGN: Patients with age < 85 years, ECOG-performance status (PS) < 3, and adequate renal, hepatic and hematologic function were eligible. NAB-P (125 mg/m2) and GEM (1000 mg/m2) day 1,8,15 every 4 weeks were employed for 3-6 cycles or until highest response. RESULTS: Overall, 147 cycles (median 4, range 1-11 cycles) were administered on thirty-seven consecutive patients (median 66 years old, range 40-82) treated. The median overall progression-free survival and OS were 6.2 and 9.2 months, respectively. The G 3-4 dose-limiting toxicity were neutropenia (20.7%), severe anemia (17.2%), and cardiovascular toxicity (10.3%). PS, number of cycles, baseline CA 19-9 and LDH serum levels, were found to be significantly related to OS. The multivariate analysis showed that both number of cycles (HR = 9.14, 95% CI 1.84-45.50, p = 0.001) and PS (HR = 13.18, 95% CI 2.73-63.71, p = 0.001) were independently associated with OS.
CONCLUSION: NAB-P/GEM regimen should be used in all patients with advanced or metastatic PC, with the exception of those with serious contraindications to chemotherapy, such as severe renal or hepatic impairment or major cardiovascular diseases
- …